Skip to main content

The reasons why you should worry about AstraZeneca vaccine

 Some European countries have temporarily suspended the use of the Oxford AstraZeneca vaccine after raising concerns over the risk of blood clots in patients who have received a dose.

Germany, France, Italy, and Spain have become the latest countries to suspend using AstraZeneca vaccine, joining Ireland, Denmark, Thailand, the Netherlands, Norway, Iceland, Congo, and Bulgaria.

- A 60-year old Danish woman who died of a blood clot after receiving AstraZeneca's COVID-19 vaccine had "highly unusual" symptoms, the Danish Medicines Agency said late on Sunday. It said the woman had a low number of blood platelets and clots in small and large vessels, as well as bleeding.

- One Austrian woman died from "severe blood coagulation problems", 10 days after receiving the vaccine but no clear link has been made between the administration of her jab and her death a full inquiry is ongoing.

- Two Italians are thought to have died shortly after receiving the vaccine.

- Last week the Norwegian Medicines Agency said that it was investigating an unexpected fatal brain haemorrhage in a patient who had received the AstraZeneca jab as well as “several” reports of symptoms that could be a sign of reduced blood platelet counts.

Read more: What should you do before and after getting a COVID-19 vaccine

-------------------

Read more: COVID-19 vaccines profits in 2021

- On Saturday, Norwegian authorities reported that four people under the age of 50 who had received the AstraZeneca vaccine had an unusually low number of blood platelets, which could lead to severe bleeding.

- Over the weekend The European Medicines Agency (EMA) said it had received “three more reports of severe cases of blood clots or brain haemorrhages in younger people who have received the AstraZeneca vaccine”.

European vaccination programmes have been upset in the last two weeks by reports that recipients of the AstraZeneca inoculation have suffered blood clots.

it is known that blood clots that form in the arms, legs or elsewhere can sometimes break free and travel to the heart, brain or lungs, causing strokes, heart attacks or a deadly blockage of blood flow.

Read more: The reasons why second dose of COVID-19 vaccine has worse side effects

------------------

Read more: The side effects of COVID-19 vaccines and messages from volunteers 

Covid-19 vaccines are still experimental, scientists must investigate every possibility that the shot could have some unforeseen side effects. The shots are considered experimental because the vaccines were only developed in the last year, so there is no long-term data for any of them.

AstraZeneca said on Sunday that out of 17 million people who have received its vaccine across the UK and the EU, there have been 15 cases of deep vein thrombosis and 22 events of pulmonary thrombosis (both serious blood clotting disorders).

The drug company said these numbers were “much lower than would be expected to occur naturally in a general population of this size”.

The European Medicines Agency (EMA) said suspending use of the AstraZeneca vaccine is "a precaution taken in the light of their national situation.” But the EMA as well as the World Health Organization said data does not show the vaccine caused the clots and people should keep getting vaccinated with it because the benefit outweighs the risk.

Read more: Comparing vaccines: country of origin, safety, efficacy, and approval

“People die every day, and we have more than 300 million people globally who have been immunised who will die of other causes,” said Dr. Mariangela Simao, an assistant director-general at the WHO.

For more articles, you can read that here Homepage

Designed by Open Themes & Nahuatl.mx.